KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Dr Julia Wong speaks to ecancer about the FABREC study.
This study was conducted to compare the quality of life and clinical outcomes of patients who underwent accelerated radiation therapy versus conventional radiation therapy after post-mastectomy breast reconstruction using implants or tissue expanders.
Dr Wong discusses the study's findings, which highlighted small improvements in quality of life scores among younger patients who received hypofractionated radiation therapy.
To read more about this study, click here.
KEYNOTE-756 trial shows increased response in ER+/HER2- breast cancer
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
The Southeast Asian Breast Cancer Symposium; background, aims and successes
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Advancing breast cancer diagnosis in the developing world
Novel antibody-drug conjugates (ADCs) technologies for management of mBC